Incidence, Microbiological Profile, Antimicrobial Resistance Patterns, and Risk Factors of Haemodialysis Catheter-Related Infections: A Prospective Observational Study
This prospective observational study of 112 haemodialysis patients found a 14.2% incidence of catheter-related infections driven primarily by resistant Gram-negative organisms, with advanced age and frequent dialysis sessions identified as significant risk factors, underscoring the need for culture-guided therapy and pharmacist-supported dose optimization.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of people around the world, the kidneys have stopped doing their essential work of filtering waste from the blood. When this happens, a machine must take over, pulling blood out of the body, cleaning it, and returning it. This life-sustaining process is called hemodialysis. To connect a patient to this machine, doctors insert a thin tube, known as a catheter, into a large vein, usually in the neck. While this tube is a lifeline, it also creates a direct path for germs to enter the bloodstream. Infections that travel through these tubes are among the most serious complications patients face, often leading to longer hospital stays, more severe illness, and the need for powerful medicines that may no longer work against the invading bacteria. Understanding exactly how often these infections happen, what kinds of germs cause them, and which patients are most likely to get sick is crucial for keeping dialysis patients safe.
A team of researchers at a university hospital in Mysuru, India, set out to observe this problem directly. Over a six-month period, they followed 112 adult patients who had temporary catheters placed for their dialysis treatment. The team did not intervene in the patients' care; instead, they watched closely, recording every detail from the moment the patients arrived until they were discharged. They looked for signs of infection, such as persistent fevers, chills, or low blood pressure, and checked blood samples to identify the specific bacteria responsible. By comparing the patients who developed infections with those who did not, the researchers hoped to find patterns that could help prevent future cases.
The study revealed that infections were a significant reality for these patients. Out of the 112 people monitored, 16 developed an infection related to their catheter, meaning that roughly one in seven patients became ill during their treatment. When the researchers examined the blood samples from the infected patients, they found that the most common culprit was a type of bacteria called Escherichia coli, which is typically found in the gut but can cause severe problems when it enters the bloodstream. The team also discovered a troubling trend regarding the medicines used to fight these infections. Many of the bacteria were resistant to common antibiotics like ceftriaxone and ciprofloxacin, drugs that are often the first choice for doctors. However, the bacteria remained sensitive to a different set of stronger medicines, including tigecycline and colistin, suggesting that doctors need to be very careful about which drugs they choose.
The researchers also looked for clues about who was most likely to get an infection. They found that age and the frequency of dialysis sessions played a major role. Patients who were sixty years of age or older were significantly more likely to develop an infection than younger adults. Even more striking was the connection to the number of times a patient underwent dialysis. Those who received five or more sessions were far more likely to become infected than those who had fewer treatments. This suggests that the longer a patient relies on the catheter for repeated treatments, the higher the risk becomes. Interestingly, factors such as gender, diabetes, or specific blood counts did not show a clear link to the infections in this group of patients.
Once an infection was identified, the medical team had to decide how to treat it. In nearly half of the cases, doctors treated the infection with antibiotics alone, leaving the catheter in place. In other cases, they removed the infected tube and inserted a new one in a different spot, or they waited to insert a new tube until the infection had cleared. The most common antibiotics prescribed were vancomycin and amikacin, often given together. The treatment was largely successful, with most infected patients recovering fully before leaving the hospital. Throughout the process, clinical pharmacists played a supportive role by providing doctors with specific information, such as how to adjust the dosage of antibiotics for patients with failing kidneys, ensuring the medicine was strong enough to fight the infection but safe enough for the patient's body.
This study highlights that while catheter-related infections are a serious and frequent threat to dialysis patients, they are not random. The risk is clearly higher for older patients and those who undergo many dialysis sessions. The findings also serve as a reminder that the bacteria causing these infections are changing, becoming resistant to older, standard medicines. By paying close attention to who is most at risk and by using the right antibiotics based on laboratory results, doctors can better protect these vulnerable patients. The work underscores the importance of careful monitoring and the value of having specialists, like pharmacists, involved in the daily care to ensure that every dose of medicine is tailored precisely to the needs of the individual.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.